Instytut Hematologii i Transfuzjologii, Klinika Hematologii

Warsaw 02-776

1 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukaemia (AML), Anemia, B-cell Non-Hodgkin Lymphoma (B-NHL), Myelodysplastic Syndromes, Peripheral T Cell Lymphoma, Peripheral T-cell Lymphoma, Transformed Mycosis Fungoides

Studies at this site

• L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML — Recruiting now
• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides — Completed
• Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed